Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026, Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $192K (6,000 shares) of Immunovant, Inc. on May 20, 2026. Filing
- Last sale before this period: Dec 2, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Director | Dec 20, 2019 | Aug 28, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 28, 2026, Immunovant, Inc.: sold 1,500 shares for $65K, under a disclosed plan; 1,500 shares acquired by exercising options. 1 filing: 1
- Jul 24, 2026, Immunovant, Inc.: sold 1,500 shares for $60K, under a disclosed plan; 1,500 shares acquired by exercising options. 1 filing: 1
- Jun 26, 2026, Immunovant, Inc.: sold 1,500 shares for $57K, under a disclosed plan; 1,500 shares acquired by exercising options. 1 filing: 1
- Jun 15, 2026, Immunovant, Inc.: sold 1,500 shares for $51K, under a disclosed plan; 1,500 shares acquired by exercising options. 1 filing: 1
- May 20, 2026, Immunovant, Inc.: sold 6,000 shares for $192K, under a disclosed plan; 6,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.